Kratom Laws in Georgia 2026: HB181, HB757, HB968 — What Patients Need to Know

If you’ve searched for a direct answer to this question, you’ve probably found contradictory articles depending on when they were written. Here is the current-to-2026 picture. Restoration Recovery is an outpatient addiction clinic with a location in Ringgold, Georgia, plus three clinics in Southeast Tennessee, and we see patients weekly who are trying to make sense of what Georgia lawmakers are doing about kratom and 7-OH. This article is factual reporting on the legal landscape as of July 2026. It is not legal advice; if you have a specific legal question, consult a Georgia attorney. What we can speak to clinically is what treatment for kratom or 7-OH dependence looks like, and how it is unaffected by the regulatory questions playing out in Atlanta.

Kratom is legal for adults aged 21 and older in Georgia under the state’s 2019 Kratom Consumer Protection Act, as amended by HB181 effective January 1, 2025. The legal framework is regulatory rather than prohibitive: kratom and 7-OH products are sold through regulated retail channels, subject to age verification, labeling, laboratory testing, and display requirements. Violations carry civil penalties and product-seizure authority rather than criminal exposure for consumers. That baseline is not necessarily permanent — HB968, introduced in the 2026 session, would reclassify mitragynine and 7-OH as Schedule I controlled substances and repeal portions of the existing framework, but as of July 2026 it has not been enacted.

How Georgia’s kratom law evolved

Georgia passed a consumer-protection act in 2019, then tightened it twice (HB181 and HB757). A newer bill, HB968, would ban kratom instead. Here is the sequence, and where it stands today.

How Georgia regulates kratom (HB181 & HB757)

Georgia Governor Brian Kemp signed HB181 into law on May 2, 2024, with provisions taking effect January 1, 2025. The law amended the 2019 Kratom Consumer Protection Act, and HB757 later layered processor-registration rules on top. Together they define what a legal kratom sale in Georgia looks like:

For retail-facing enforcement, HB757 increases the state’s audit and compliance-review capacity over the products reaching Georgia shelves. In practice, Georgia’s registration rules mean fewer kratom products are legally available here than in states without them.

HB968 — the Schedule I criminalization proposal

HB968, introduced in the 2026 Georgia General Assembly session, would criminalize kratom instead of regulating it. It proposes to classify mitragynine and 7-hydroxymitragynine as Schedule I controlled substances under Georgia’s drug statute and repeal portions of the existing Kratom Consumer Protection Act.

Federal 7-OH scheduling is a separate track

State law is only part of the picture. At the federal level, kratom itself remains unscheduled under the Controlled Substances Act, but the status of concentrated 7-hydroxymitragynine products is actively in motion on a separate timeline.

• July 29, 2025: the FDA formally recommended to the DEA that concentrated 7-OH products be scheduled as Schedule I under the Controlled Substances Act. The recommendation targeted 7-OH concentrates specifically — tablets, gummies, drink mixes, and shots with elevated 7-OH concentrations — not natural whole-leaf kratom.
• DEA review is ongoing: the DEA is reviewing the FDA recommendation through its standard rulemaking process, which involves a public-comment period before any final action. Timing is uncertain; federal scheduling decisions typically take months to years.
• If federally scheduled: concentrated 7-OH products would become illegal to manufacture, sell, or possess nationwide, regardless of what any individual state does. Whole-leaf kratom would remain unscheduled at the federal level unless separately addressed.

Our companion explainer on 7-OH versus whole-leaf kratom covers the pharmacology and regulatory distinction in more depth, and our federal tracker, Is 7-OH Banned Yet? federal tracker, follows the FDA/DEA scheduling status as it develops.

What this means for Georgia residents dependent on kratom or 7-OH

This is the part of the article that matters most if you are reading this page because you are struggling to stop using kratom or 7-OH, or because someone you care about is. The legal status of kratom products does not affect whether treatment is available, effective, or covered by insurance. The medications used for kratom MAT (buprenorphine-based: Suboxone, Sublocade, Brixadi) are controlled substances with their own FDA-approved indication for opioid use disorder. The clinical protocol, insurance coverage, and 42 CFR Part 2 confidentiality protections stay the same whether or not Georgia or the federal government acts.

Kratom’s primary active alkaloids, mitragynine and 7-hydroxymitragynine, bind to the same mu-opioid receptors that fentanyl, heroin, and prescription opioids act on. Although kratom is not itself a classical opioid, that receptor activity means the same medication-assisted treatment protocol used for opioid use disorder is clinically effective for kratom dependence. Buprenorphine, the active medication in Suboxone, Sublocade, and Brixadi, is a partial opioid agonist that relieves kratom withdrawal, suppresses craving, and provides a stable transition off kratom products over weeks rather than days.

Georgia Medicaid covers medication-assisted treatment for opioid use disorder through the Georgia Families managed care program, including the same buprenorphine-based medications used for kratom dependence. Georgia’s Medicaid care management organization (CMO) lineup can change as the state settles its next round of contracts, so members should call their specific plan or our intake team to confirm in-network status before scheduling. Restoration Recovery’s Ringgold clinic is in Catoosa County, serving patients from across North Georgia including Catoosa, Walker, Whitfield, Murray, Dade, Gordon, and Chattooga counties. The three Tennessee-side clinics also see Georgia residents routinely, particularly from counties closest to the state line; see our Find Treatment Near You directory for the broader map.

Georgia kratom law FAQ

Where to check current status

Legislation can shift during a legislative session. For the most current status of Georgia bills, the Georgia General Assembly maintains bill-tracking pages for each active bill at legis.ga.gov. Independent trackers like BillTrack50 and LegiScan also show committee actions, voting records, and full bill text. For the federal 7-OH picture, FDA and DEA press releases and notices in the Federal Register are the authoritative sources. We update our Tennessee kratom law article and this Georgia companion as bill status changes meaningfully.

This article is published for patient information only. It is not legal advice. If you have a specific legal question about your situation, consult a Georgia attorney licensed to practice in your jurisdiction.

If you are ready to stop

Whatever the Georgia General Assembly does with HB968 this year, the clinical reality for kratom and 7-OH dependence is stable. Buprenorphine-based MAT works, same-week appointments are available at our Ringgold clinic and our three Southeast Tennessee locations, and most insurance plans (including Georgia Medicaid through the Georgia Families program) cover treatment. Call 423-498-2000 or submit a contact request when you are ready.

Related reading